Beijing SL Pharmaceutical Co., Company Profile - Aug 14, 2011

Document Sample
Beijing SL Pharmaceutical Co.,  Company Profile - Aug 14, 2011 Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Beijing SL Pharmaceutical Co., Ltd.
                                                                                         440 Wheelers Farms Road
                                                                                         Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Chinese Renmimbi

                                 Wright Quality Rating:BAA20                                  Key Data

   Beijing SL Pharmaceutical Co., Ltd. is principally engaged in the development,             Ticker:
   production and sale of gene engineering drugs. The Company provides four                   002038
   categories of products: biological products, including rhG-CSF injections, interleukin-
   2 injections, rhIL-11 injections and rh-bFGF; biochemicals, such as cytidine disodium      2010 Sales:
   triphosphate for injection, calcium folinate for injection, salmon calcitonin injection,
                                                                                              457,842,000
   coenzyme complex for injection, netilmicin sulfate injection, matrine injection and
   ciclosporin injection; tablets and capsules, including desloratadine orally-
   disintegrating tablets, zaleplon capsules, naftopidil tablets, tropisetron hydrochloride   Major Industry:
   capsules, telmisartan tablets, metformin hydrochloride and glyburide tablets and           Drugs, Cosmetics & Health
   stavudine capsules, and health-care food, including Hongxin Capsule. It distributes        Care
   its products in domestic and overseas markets.
                       Stock Chart                                  Officers                  Sub Industry:
                                                               Chairman & General             Ethical Drug Manufacturers
                                                                    Manager
                                                                    Mingbo Xu                 Country:
                                                                                              China
                                                               Chief Financial Officer
                                                                     Wenying Xi               Currency:
                                                                                              Chinese Renmimbi

                                                                                              Fiscal Year Ends:
                                                                                              December

                                                                                              Employees
                                                                                              376

                                                                                              Exchanges:
                                                                                              SZN

                                                                                              Share Type:
                                                                            
				
DOCUMENT INFO
Description: Beijing SL Pharmaceutical Co., Ltd. is principally engaged in the development, production and sale of gene engineering drugs. The Company provides four categories of products: biological products, including rhG-CSF injections, interleukin-2 injections, rhIL-11 injections and rh-bFGF; biochemicals, such as cytidine disodium triphosphate for injection, calcium folinate for injection, salmon calcitonin injection, coenzyme complex for injection, netilmicin sulfate injection, matrine injection and ciclosporin injection; tablets and capsules, including desloratadine orally-disintegrating tablets, zaleplon capsules, naftopidil tablets, tropisetron hydrochloride capsules, telmisartan tablets, metformin hydrochloride and glyburide tablets and stavudine capsules, and health-care food, including Hongxin Capsule. It distributes its products in domestic and overseas markets.
BUY THIS DOCUMENT NOW PRICE: $24.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.